These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 23742830)

  • 81. Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
    Shomali W; Hachem R; Chaftari AM; Jiang Y; Bahu R; Jabbour J; Raad S; Al Shuaibi M; Al Wohoush I; Raad I
    Cancer; 2012 Dec; 118(23):5823-9. PubMed ID: 22605389
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.
    Fujisaka T; Fujita SI; Maeda D; Shibata K; Takahashi H; Morita H; Takeda Y; Ito T; Sohmiya K; Hoshiga M; Ishizaka N
    Heart Vessels; 2017 Nov; 32(11):1327-1336. PubMed ID: 28589505
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
    Riisbro R; Christensen IJ; Piironen T; Greenall M; Larsen B; Stephens RW; Han C; Høyer-Hansen G; Smith K; Brünner N; Harris AL
    Clin Cancer Res; 2002 May; 8(5):1132-41. PubMed ID: 12006529
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Prognostic value of soluble urokinase plasminogen activator receptor in patients presenting to the emergency department with chest pain suggestive of acute coronary syndrome.
    Chenevier-Gobeaux C; Lemarechal H; Doumenc B; Peschanski N; Claessens YE; Borderie D; Ray P
    Clin Biochem; 2021 Jun; 92():19-24. PubMed ID: 33662350
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The role of soluble urokinase plasminogen activator receptor (suPAR) in the diagnostics of diabetic foot infection.
    Aslan S; Demirdal T; Erbak H; Aslan C
    Infect Dis (Lond); 2020 Feb; 52(2):107-113. PubMed ID: 31713451
    [No Abstract]   [Full Text] [Related]  

  • 86. Procalcitonin and C-reactive protein serum levels as markers of infection in a pediatric population with febrile neutropenia and cancer.
    Martinez-Albarran M; Perez-Molina Jde J; Gallegos-Castorena S; Sanchez-Zubieta F; Del Toro-Arreola S; Troyo-Sanroman R; Gonzalez-Ramella O
    Pediatr Hematol Oncol; 2009 Sep; 26(6):414-25. PubMed ID: 19657991
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Initial procalcitonin level predicts infection and its outcome in patients with non-Hodgkin lymphoma with febrile neutropenia.
    Liu X; Wang DF; Fang Y; Ye WF; Liu S; Lou N
    Leuk Lymphoma; 2015 Jan; 56(1):85-91. PubMed ID: 24707944
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8.
    Engel A; Steinbach G; Kern P; Kern WV
    Scand J Infect Dis; 1999; 31(2):185-9. PubMed ID: 10447330
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Soluble urokinase-type plasminogen activator receptor levels in patients with burn injuries and inhalation trauma requiring mechanical ventilation: an observational cohort study.
    Backes Y; van der Sluijs KF; Tuip de Boer AM; Hofstra JJ; Vlaar AP; Determann RM; Knape P; Mackie DP; Schultz MJ
    Crit Care; 2011; 15(6):R270. PubMed ID: 22085408
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia.
    Persson L; Engervall P; Magnuson A; Vikerfors T; Söderquist B; Hansson LO; Tidefelt U
    Scand J Infect Dis; 2004; 36(5):365-71. PubMed ID: 15287382
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Soluble urokinase-type plasminogen activator receptor as a putative marker of male accessory gland inflammation.
    Autilio C; Morelli R; Milardi D; Grande G; Marana R; Pontecorvi A; Zuppi C; Baroni S
    Andrology; 2015 Nov; 3(6):1054-61. PubMed ID: 26384478
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Can mannose-binding lectin and plasma level of soluble urokinase receptor be used in diagnosis and treatment monitorization of brucellosis patients?].
    Karsen H; Cesur S; Karaağaç L; Binici I; Fidan Y; Oğüş E; Demiröz AP
    Mikrobiyol Bul; 2012 Jul; 46(3):519-21. PubMed ID: 22951667
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
    Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
    Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II.
    Fleischhack G; Kambeck I; Cipic D; Hasan C; Bode U
    Br J Haematol; 2000 Dec; 111(4):1093-102. PubMed ID: 11167745
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Plasma-soluble urokinase plasminogen activator receptor (suPAR) levels in Behçet's disease and correlation with disease activity.
    Saylam Kurtipek G; Kesli R; Tuncez Akyurek F; Akyurek F; Ataseven A; Terzi Y
    Int J Rheum Dis; 2018 Apr; 21(4):866-870. PubMed ID: 27171829
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Can soluble urokinase plasminogen receptor predict outcomes after cardiac surgery?
    Schultz-Swarthfigure CT; McCall P; Docking R; Galley HF; Shelley B
    Interact Cardiovasc Thorac Surg; 2021 Jan; 32(2):236-243. PubMed ID: 33236082
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Soluble urokinase-type plasminogen activator receptor and ferritin concentration in patients with advanced alimentary tract carcinoma. Relationship to localization, surgical treatment and the stage of the disease--preliminary report.
    Usnarska-Zubkiewicz L; Strutyńska-Karpińska M; Zubkiewicz-Kucharska A; Zarębski P; Grabowski K
    Adv Clin Exp Med; 2014; 23(6):959-67. PubMed ID: 25618124
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Serum levels of soluble urokinase plasminogen activator receptor (suPAR) as a marker of tuberculosis treatment efficacy.
    Indumati V; Vijay V; Krishnaswamy D; Rajeshwari V; Ramesh A; Shantala D; Shilpa A
    Indian J Tuberc; 2017 Jul; 64(3):206-211. PubMed ID: 28709490
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters.
    Ventorp F; Gustafsson A; Träskman-Bendz L; Westrin Å; Ljunggren L
    PLoS One; 2015; 10(10):e0140052. PubMed ID: 26451727
    [TBL] [Abstract][Full Text] [Related]  

  • 100. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
    Zhao Y; Li C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.